ArticleFrontiers in endocrinology2024

HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors.

Mayu Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.